J.Jpn. Surg. Soc.. 84(9): 796-799, 1983
Report on the annual meeting
BASIC AND CLINICAL STUDIES ON METASTATIC CANCER
－With Special Reference of Multidisciplinary Treatment of Gastric and Colorectal Cancer Patients with Hepatic Meatstasis－
|
Second Department of Surgery, School of Medicine, Chiba University, Chiba, Japan Kazuaki Okuyama, Kaichi Isono, Hirotoshi Satoh, Shoichi Onoda, Noriyuki Tohnosu, Yoshikazu Yamamoto, Munemasa Ryu, Yoshio Koide, Masayuki Kimura, Akihiro Hanaoka, Takenori Ochiai, Michio Odaka, Hiroshi Satoh |
The effective treatment for synchronous hepatic metastasis was regarded as the group with surgical removal of the primary lesion plus hepatic resection plus chemotherapy, demonstrating most favorable prognosis in both gastric and colorectal cancer patients. Prognosis of the group treated with surgical removal of the primary lesion plus hepatic resection plus chemotherapy, was the most excellent and was folowed by the group with surgical removal of the primary lesion plus chemotherapy and group with surgical removal of the primary lesions and group surgical removal of the primary lesion in this order.
Concerning chemotherapy after surgical removal of the primary lesion, continuous intraarterial infusion therapy with FML regimen combining Lentinan revealed more favorable prognosis also in both gastric and colorectal cancer patients.
Hepatic resection with aggresive reduction surgery was of significance in the treatment for the patients with hepatic metastasis of H1 and H2. Long-term survival is also expected for the patients with metachronous hepatic metastasis of H1 by hepatic resection plus chemotherapy.
To read the PDF file you will need Adobe Reader installed on your computer.